Group 4F: Oligometastatic Breast Cancer

Name: Group 4F: Oligometastatic Breast Cancer
Start: 2023-12-15
End: 2023-12-15

Poster #PO5-18-12: Can we cure de novo oligometastatic stage IV HER2+ breast cancer with multimodality therapy? (CHLOE).

Poster #PO2-06-02: Characteristics and treatment patterns of de novo oligometastatic stage IV breast cancer: A single-center retrospective cohort study.